1Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey.
2Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Neurosurg Focus. 2024 Mar;56(3):E15. doi: 10.3171/2023.12.FOCUS23801.
Ethmoidal dural arteriovenous fistulas (DAVFs) are often associated with cortical venous drainage (CVD) and a higher incidence of hemorrhage compared with DAVFs in other locations. They may be treated with open surgical disconnection or with endovascular treatment (EVT). In this systematic review and meta-analysis, the authors compare the outcomes of ethmoidal DAVFs treated with open microsurgery versus EVT and report four additional cases of ethmoidal DAVFs treated with open microsurgery in their institution.
A literature search of the PubMed and Scopus databases was conducted between December 2021 and May 2022 to identify relevant articles published between 1990 and 2021 using the PRISMA guidelines. References were reviewed and screened by two authors independently, and disagreements were resolved through consensus. Exclusion criteria included non-English-language studies, those with an incorrect study design, those reporting DAVFs in a nonethmoidal location, and studies whose outcomes were not stratified based on DAVF location. Inclusion criteria were any studies reporting on ethmoidal DAVFs treated by either microsurgery or EVT. A risk of bias assessment was performed using the Newcastle-Ottawa Scale. The authors performed a pooled proportional meta-analysis to compare patient outcomes.
Twenty studies were included for analysis. Of 224 patients, 142 were treated with surgery, while 103 were treated with EVT. Seventy percent (148/210) of the patients were symptomatic at presentation, with hemorrhage being the most common presentation (48%). CVD was present in 98% of patients and venous ectasia in 61%. The rates of complete DAVF obliteration with surgery and EVT were 89% and 70%, respectively (95% CI -30% to -10%, p < 0.03). Twenty percent (21/103) of endovascularly treated fistulas required subsequent surgery. Procedure-related complications occurred in 10% of the surgical cases, compared with 13% of the EVT cases. The authors' case series included 4 patients with ethmoidal DAVFs treated surgically with complete obliteration, without any postoperative complications.
The complete obliteration rates of ethmoidal DAVF appear to be higher and more definitive with microsurgical intervention than with EVT. While complication rates between the two procedures seem similar, patients treated with EVT may require further interventions for definitive treatment. The limitations of this study include its retrospective nature, the quality of studies included, and the continued evolving technologies of EVT. Future studies should focus on the association between venous drainage pattern and the proclivity toward venous ectasia or rate of hemorrhage at presentation.
筛骨硬脑膜动静脉瘘(DAVF)常与皮质静脉引流(CVD)相关,且与其他部位的 DAVF 相比,其出血发生率更高。筛骨 DAVF 可采用开放式显微手术或血管内治疗(EVT)进行治疗。在本系统评价和荟萃分析中,作者比较了采用开放式显微手术与 EVT 治疗筛骨 DAVF 的结果,并报告了其机构中另外 4 例采用开放式显微手术治疗的筛骨 DAVF 病例。
2021 年 12 月至 2022 年 5 月,作者按照 PRISMA 指南,对 PubMed 和 Scopus 数据库进行文献检索,以确定 1990 年至 2021 年期间发表的相关文章。由两位作者独立对参考文献进行了审查和筛选,并通过共识解决了分歧。排除标准包括非英语语言的研究、研究设计不正确的研究、报告非筛骨部位 DAVF 的研究,以及未根据 DAVF 部位对结果进行分层的研究。纳入标准为任何报告采用显微手术或 EVT 治疗筛骨 DAVF 的研究。采用纽卡斯尔-渥太华量表进行偏倚风险评估。作者进行了荟萃比例 meta 分析以比较患者结局。
20 项研究被纳入分析。224 例患者中,142 例接受了手术治疗,103 例接受了 EVT 治疗。70%(148/210)的患者在就诊时存在症状,其中最常见的表现是出血(48%)。98%的患者存在皮质静脉引流(CVD),61%的患者存在静脉扩张。手术和 EVT 治疗的完全 DAVF 闭塞率分别为 89%和 70%(95%CI -30%至-10%,p < 0.03)。20%(21/103)的经血管内治疗的瘘管需要后续手术治疗。手术病例的与手术相关的并发症发生率为 10%,而 EVT 病例为 13%。作者的病例系列包括 4 例接受筛骨 DAVF 手术治疗的患者,均完全闭塞,无术后并发症。
与 EVT 相比,筛骨 DAVF 采用显微外科干预的完全闭塞率似乎更高且更明确。虽然两种治疗方法的并发症发生率相似,但接受 EVT 治疗的患者可能需要进一步的干预措施以进行确定性治疗。本研究的局限性包括其回顾性研究性质、纳入研究的质量以及 EVT 技术的持续发展。未来的研究应侧重于静脉引流模式与静脉扩张或就诊时出血倾向之间的关系。